Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Gynecology

  Free Subscription


25.03.2024

4 Acta Obstet Gynecol Scand
5 Am J Obstet Gynecol
2 Am J Surg Pathol
1 Aust N Z J Obstet Gynaecol
4 BMC Cancer
2 BMJ
1 Cancer
1 Diagn Cytopathol
5 Eur J Obstet Gynecol Reprod Biol
3 Fertil Steril
2 Gynecol Endocrinol
9 Gynecol Oncol
7 Hum Reprod
10 Int J Gynaecol Obstet
3 JAMA
1 Lancet
5 Obstet Gynecol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. LI Y, Wu IXY, Wang X, Song J, et al
    Immunological parameters of maternal peripheral blood as predictors of future pregnancy outcomes in patients with unexplained recurrent pregnancy loss.
    Acta Obstet Gynecol Scand. 2024 Mar 21. doi: 10.1111/aogs.14832.
    PubMed         Abstract available

  2. KACEROVSKY M, Hornychova H, Jaiman S, Pavlikova L, et al
    Angiogenic imbalance in pregnancies with preterm prelabor rupture of membranes between 34 and 37 weeks of gestation.
    Acta Obstet Gynecol Scand. 2024 Mar 21. doi: 10.1111/aogs.14833.
    PubMed         Abstract available

  3. BRIK M, Sandonis M, Hernandez-Fleury A, Gil J, et al
    Cannabis exposure during pregnancy and perinatal outcomes: A cohort study.
    Acta Obstet Gynecol Scand. 2024 Mar 19. doi: 10.1111/aogs.14818.
    PubMed         Abstract available

  4. THUNBO MO, Vendelbo JH, Witte DR, Larsen A, et al
    Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018.
    Acta Obstet Gynecol Scand. 2024 Mar 15. doi: 10.1111/aogs.14805.
    PubMed         Abstract available


    Am J Obstet Gynecol

  5. ONUOHA C, Schulte CCM, Thaweethai T, Hsu S, et al
    The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity.
    Am J Obstet Gynecol. 2024 Mar 14:S0002-9378(24)00438.
    PubMed         Abstract available

  6. PRENSKY LM
    Fetal fraction in noninvasive prenatal testing and adverse pregnancy outcomes.
    Am J Obstet Gynecol. 2024 Mar 18:S0002-9378(24)00443.
    PubMed        

  7. OYELESE Y, Javinani A, Gudanowski B, Krispin E, et al
    Vasa Previa in Singleton Pregnancies: Diagnosis and Clinical Management Based on an International Expert Consensus.
    Am J Obstet Gynecol. 2024 Mar 15:S0002-9378(24)00442.
    PubMed         Abstract available

  8. WESTERBERG AC, Langeland Degnes MH, Andresen IJ, Paasche Roland MC, et al
    Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia.
    Am J Obstet Gynecol. 2024 Mar 15:S0002-9378(24)00441.
    PubMed         Abstract available

  9. BECKING EC, Sistermans EA, Bekker MN
    Fetal fraction in noninvasive prenatal testing and adverse pregnancy outcomes: a response.
    Am J Obstet Gynecol. 2024 Mar 15:S0002-9378(24)00444.
    PubMed        


    Am J Surg Pathol

  10. KATSAKHYAN L, Shahi M, Eugene HC, Nonogaki H, et al
    Uterine Leiomyosarcoma Associated With Perivascular Epithelioid Cell Tumor: A Phenomenon of Differentiation/Dedifferentiation and Evidence Suggesting Cell-of-Origin.
    Am J Surg Pathol. 2024 Mar 18. doi: 10.1097/PAS.0000000000002208.
    PubMed         Abstract available

  11. FADARE O, Fard EV, Bhargava R, Desouki MM, et al
    The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases.
    Am J Surg Pathol. 2024 Mar 21. doi: 10.1097/PAS.0000000000002201.
    PubMed         Abstract available


    Aust N Z J Obstet Gynaecol

  12. MAUNDER A, Arentz S, Armour M, Costello MF, et al
    Health needs, treatment decisions and experience of traditional complementary and integrative medicine use by women with diminished ovarian reserve: A cross-sectional survey.
    Aust N Z J Obstet Gynaecol. 2024 Mar 21. doi: 10.1111/ajo.13805.
    PubMed         Abstract available


    BMC Cancer

  13. YANG S, Du J, Wang W, Zhou D, et al
    APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer.
    BMC Cancer. 2024;24:364.
    PubMed         Abstract available

  14. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
    BMC Cancer. 2024;24:351.
    PubMed         Abstract available

  15. CUI X, Wang H, Chen M, Seery S, et al
    Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
    BMC Cancer. 2024;24:349.
    PubMed         Abstract available

  16. ZHANG K, Wang T, Liu Z, He J, et al
    Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real world.
    BMC Cancer. 2024;24:360.
    PubMed         Abstract available


    BMJ

  17. NASH Z, Davies M
    Premature ovarian insufficiency.
    BMJ. 2024;384:e077469.
    PubMed        

  18. TANNE JH
    US abortions reached record high in 2023 despite legal restrictions, though access varies.
    BMJ. 2024;384:q715.
    PubMed        


    Cancer

  19. NIERENGARTEN MB
    Promising new treatment approaches for locally advanced cervical cancer.
    Cancer. 2024;130:1192.
    PubMed        


    Diagn Cytopathol

  20. MAHAJAN P, Kaur P
    Improving cervical cancer classification in PAP smear images with enhanced segmentation and deep progressive learning-based techniques.
    Diagn Cytopathol. 2024 Mar 22. doi: 10.1002/dc.25295.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  21. ASHMORE AA, Abdul S, Phillips A, Bali A, et al
    Regular follow-up with cervical cytology is of questionable value following surgical treatment of microinvasive cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:307-310.
    PubMed         Abstract available

  22. HU Y, Ye Z, Obore N, Guo X, et al
    Non-invasive prediction model of histologic chorioamnionitis with preterm prelabour rupture of membranes.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:299-306.
    PubMed         Abstract available

  23. ABERSEK N, Tsiartas P, Soucek O, Andrys C, et al
    Characterizing of intra-amniotic inflammatory changes associated with chronic inflammation in the placenta marked by elevated amniotic fluid interferon gamma-induced protein 10 (IP-10) in pregnancies complicated by preterm prelabor rupture of membrane
    Eur J Obstet Gynecol Reprod Biol. 2024;296:292-298.
    PubMed         Abstract available

  24. SHEN P, Fu J, Zhang W, Chen C, et al
    A comparative study of two pelvimetry methods: 3D models based on CT and MRI.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:286-291.
    PubMed         Abstract available

  25. SHAAMASH AH, AlQasem MH, Mahfouz AA, Al Ghamdi DS, et al
    Major placenta previa among patients with and without previous cesarean section: Maternal characteristics, outcomes and risk factors.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:280-285.
    PubMed         Abstract available


    Fertil Steril

  26. LIN T, Allaire C, As-Sanie S, Stratton P, et al
    World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: V. physical examination standards in endometriosis research.
    Fertil Steril. 2024 Mar 18:S0015-0282(24)00178.
    PubMed         Abstract available

  27. ZIPPONI M, Lee DY, Stratopoulou CA, Cacciottola L, et al
    Characterization of microRNA exosome content from endometrioma wall in vitro culture.
    Fertil Steril. 2024 Mar 16:S0015-0282(24)00181.
    PubMed        

  28. RAIMONDO D, Raspollini A, Bertoldo L, Ferla S, et al
    Laparoscopic medulla-sparing ovarian tissue biopsy for cryopreservation: step-by-step surgical technique.
    Fertil Steril. 2024 Mar 14:S0015-0282(24)00182.
    PubMed         Abstract available


    Gynecol Endocrinol

  29. WU Y, Liu C, Huang J, Wang F, et al
    Quantitative proteomics reveals pregnancy prognosis signature of polycystic ovary syndrome women based on machine learning.
    Gynecol Endocrinol. 2024;40:2328613.
    PubMed         Abstract available

  30. GARCIA-VIGARA A, Fernandez-Garrido J, Chedraui P, Monllor-Tormos A, et al
    Association between anxiety and frailty in postmenopausal women.
    Gynecol Endocrinol. 2024;40:2329714.
    PubMed         Abstract available


    Gynecol Oncol

  31. GASS P, Thiel FC, Haberle L, Ackermann S, et al
    Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
    Gynecol Oncol. 2024;183:25-32.
    PubMed         Abstract available

  32. CACCIOTTOLA L, Camboni A, Gatti E, Marbaix E, et al
    Fertility potential and safety assessment of residual ovarian cortex in young women diagnosed with epithelial borderline and early-stage malignant ovarian tumors.
    Gynecol Oncol. 2024;183:15-24.
    PubMed         Abstract available

  33. ROSS DH, Gomez K, Harmon G, Mysz ML, et al
    Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer.
    Gynecol Oncol. 2024;183:33-38.
    PubMed         Abstract available

  34. LEVINE BJ
    Letter re: Ban et al., A personalized probabilistic approach to ovarian cancer diagnostics.
    Gynecol Oncol. 2024 Mar 15:S0090-8258(24)00155.
    PubMed        

  35. BYRNE M, Sia TY, Fong C, Khurram A, et al
    Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
    Gynecol Oncol. 2024 Mar 14:S0090-8258(24)00144.
    PubMed         Abstract available

  36. MCNAMARA B, Demirkiran C, Hartwich TMP, Bellone S, et al
    Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer.
    Gynecol Oncol. 2024 Feb 9:S0090-8258(24)00043.
    PubMed         Abstract available

  37. FADER AN, Ko EM, Pollock BD, Blank SV, et al
    An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?
    Gynecol Oncol. 2024 Jan 25:S0090-8258(24)00002.
    PubMed         Abstract available

  38. HARTMAN YAW, Kenkhuis MF, Stelten S, Brouwer CG, et al
    Demographic, clinical, and sociocognitive determinants related to physical activity and dietary intake in patients with ovarian cancer: A cross-sectional study.
    Gynecol Oncol. 2024;183:39-46.
    PubMed         Abstract available

  39. AHSAN MD, Webster EM, Wolfe IA, McGonigle R, et al
    Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic.
    Gynecol Oncol. 2024;183:47-52.
    PubMed         Abstract available


    Hum Reprod

  40. VIDAL MDM, Martinez F, Rodriguez I, Polyzos NP, et al
    Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
    Hum Reprod. 2024 Mar 18:deae047. doi: 10.1093.
    PubMed         Abstract available

  41. ATA B
    Progestin-primed ovarian stimulation and aneuploidy, innocent until proven guilty.
    Hum Reprod. 2024 Mar 18:deae051. doi: 10.1093.
    PubMed        

  42. DE VOS ES, Mulders AGMGJ, Koning AHJ, Willemsen SP, et al
    Morphologic development of the first-trimester utero-placental vasculature is positively associated with embryonic and fetal growth: the Rotterdam Periconception Cohort.
    Hum Reprod. 2024 Mar 19:deae056. doi: 10.1093.
    PubMed         Abstract available

  43. CHEMERINSKI A, Shen M, Valero-Pacheco N, Zhao Q, et al
    The impact of ovarian stimulation on the human endometrial microenvironment.
    Hum Reprod. 2024 Mar 20:deae048. doi: 10.1093.
    PubMed         Abstract available

  44. WANG H, Wang B, Wu M, Lu J, et al
    Targeting osteopontin alleviates endometriosis and inflammation by inhibiting the RhoA/ROS axis and achieves non-invasive in vitro detection via menstrual blood.
    Hum Reprod. 2024 Mar 20:deae052. doi: 10.1093.
    PubMed         Abstract available

  45. TEEDE HJ, Neven ACH, Pena A
    Evolution of evidence-based diagnostic criteria in adolescents with polycystic ovary syndrome.
    Hum Reprod. 2024 Mar 21:deae050. doi: 10.1093.
    PubMed        

  46. KIM JJ, Hwang KR, Lee D, Kim S, et al
    Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
    Hum Reprod. 2024 Mar 21:deae042. doi: 10.1093.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  47. DREW RJ, Eogan M
    Treatment of Mycoplasma genitalium infection in pregnancy: A systematic review of international guidelines.
    Int J Gynaecol Obstet. 2024 Mar 15. doi: 10.1002/ijgo.15469.
    PubMed         Abstract available

  48. GIORGI M, Raimondo D, Pacifici M, Bartiromo L, et al
    Adenomyosis among patients undergoing postpartum hysterectomy for uncontrollable uterine bleeding: A multicenter, observational, retrospective, cohort study on histologically-based prevalence and clinical characteristics.
    Int J Gynaecol Obstet. 2024 Mar 18. doi: 10.1002/ijgo.15452.
    PubMed         Abstract available

  49. IGBODIKE EP, Iwuala IC, Maduako RO, Eleje GU, et al
    Ovarian torsion-detorsion in a 10-year premenarchial female with chronic recurrent abdominal pain misdiagnosed as 'ama-afo' in a suburb: A case report.
    Int J Gynaecol Obstet. 2024 Mar 19. doi: 10.1002/ijgo.15460.
    PubMed        

  50. NIETO-CALVACHE AJ, Fox KA, Jauniaux E, Maya J, et al
    Is telehealth useful in the management of placenta accreta spectrum in low-resource settings? Results of an exploratory survey.
    Int J Gynaecol Obstet. 2024 Mar 20. doi: 10.1002/ijgo.15474.
    PubMed         Abstract available

  51. SEGOVIA JM, Cantor EA, Vargas HA, Sanabria DE, et al
    Letter to the Editor: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15475.
    PubMed        

  52. MUTCH D, Gaffney D, Matias-Guiu X, Fotopoulou C, et al
    Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15478.
    PubMed        

  53. AMIKAM U, Baghlaf H, Badeghiesh A, Brown R, et al
    Idiopathic intracranial hypertension and obstetric and neonatal outcomes: A 1:20 matched study from a population database.
    Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15481.
    PubMed         Abstract available

  54. LEVY R, Sela HY, Weiss A, Rotem R, et al
    Impact of prior use of topical hemostatic agents on trial of labor after cesarean: Insights from a multicenter cohort study.
    Int J Gynaecol Obstet. 2024;165:203-210.
    PubMed         Abstract available

  55. GEAGEA V, Echtay L, Salman F, Ghaname W, et al
    Isolated torsion of the fallopian tube associated with hematosalpinx in a 17-year-old adolescent: A case report.
    Int J Gynaecol Obstet. 2024;165:382-383.
    PubMed        

  56. PATEL A, Suneja A, Malik R, Gupta B, et al
    Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
    Int J Gynaecol Obstet. 2024;165:169-175.
    PubMed         Abstract available


    JAMA

  57. MENG J, Tang H, Gao S
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:617-618.
    PubMed        

  58. PARK Y, Kim NE, Lee SJ
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:618.
    PubMed        

  59. DUNNE F, Newman C, Smyth A
    Early Metformin Treatment for Gestational Diabetes-Reply.
    JAMA. 2024;331:618-619.
    PubMed        


    Lancet

  60. DADOUN S, Demmler-Harrison GJ, Ketwaroo P, Castro EC, et al
    Congenital toxoplasmosis of the brain caused by infection in late pregnancy.
    Lancet. 2024;403:1081-1082.
    PubMed        


    Obstet Gynecol

  61. LI R, Fang Z, Zhou Q, Fu J, et al
    Postpartum Necrotizing Myositis With Endometrial Prolapse.
    Obstet Gynecol. 2024 Mar 22. doi: 10.1097/AOG.0000000000005556.
    PubMed         Abstract available

  62. LEE MW, Anderson ZS, Girma AM, Klar M, et al
    Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma.
    Obstet Gynecol. 2024 Mar 21. doi: 10.1097/AOG.0000000000005562.
    PubMed         Abstract available

  63. CHEN TX
    Utility of Office Hysteroscopy in Diagnosing Retained Products of Conception Following Early Pregnancy Loss After In Vitro Fertilization.
    Obstet Gynecol. 2024;143:e129.
    PubMed        

  64. PARKER W, Pickett C, Binder P
    Variables Associated With Resolution and Persistence of Ovarian Cysts.
    Obstet Gynecol. 2024;143:e129.
    PubMed        

  65. VENKATESH A, Isaacs C
    Trends in Uterine Cancer Mortality in the United States: A 50-Year Population-Based Analysis.
    Obstet Gynecol. 2024;143:e130-e131.
    PubMed        


    PLoS One

  66. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    PubMed         Abstract available

  67. MIKHAEL S, Kurdi A, Khoueiry-Zgheib N, Tahtouh R, et al
    Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
    PLoS One. 2024;19:e0298127.
    PubMed         Abstract available

  68. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.